Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1b study is to investigate whether intravenous administration of
REOLYSIN® in combination with chemotherapy and pembrolizumab is effective and safe in the
treatment of pancreatic adenocarcinoma.